Gout & Uric Acid: A Comprehensive Nutritional and Natural-Health Reference
1. Definition and Overview
Gout is an inflammatory arthritis triggered by the deposition of monosodium urate (MSU) crystals in joints, soft tissues, and bones. It is the most common form of inflammatory arthritis and is characterized by acute intermittent episodes of synovitis presenting with joint swelling and pain, referred to as acute gouty arthritis, acute gout attacks, or acute gout flares. It has been described as a disease of the foot since antiquity, and approximately 8 million patients in the United States have gout.
Gout is a common sterile inflammatory disease caused by abnormal purine metabolism. Uric acid is the final product of purine metabolism in the human body, and the pathogenesis of gout involves the formation and deposition of MSU crystals in tissues due to elevated serum uric acid.
Hyperuricemia, the biochemical precursor to gout, is defined by a serum urate above 7 mg/dL. Epidemiological studies in the United States have generally accepted 7.0 mg/dL as the upper limit in adult men and 6.0 mg/dL in women. The solubility threshold of urate is 6.8 mg/dL; urate concentrations above this threshold lead to crystal deposition, while levels below this threshold lead to crystal dissolution.
Most people with hyperuricemia are asymptomatic (85% to 90%), but elevated uric acid levels in the blood or urine can lead to gout or nephrolithiasis. Dietary purines are responsible for about one-third of the body's daily serum uric acid production; the rest is synthesized from endogenous sources.
2. Presentation and Clinical Stages
Gout initially presents as an episode of acute inflammatory arthritis, most commonly involving the first metatarsophalangeal joint, a condition commonly referred to as podagra. Typical attacks during the first few years last 7 to 14 days before resolving. Over time, these attacks become prolonged and can become chronic.
During a gout attack, the patient complains of red, hot, swollen joints, often including the big toe. In some patients, acute gout attacks become progressively more frequent, protracted, and severe, and may eventually progress to a chronic inflammatory condition. Additionally, in some patients, the deposits of urate crystals grow into larger collections called tophi when clinically apparent.
Advanced gout is characterized by tophi, chronic inflammatory responses, and structural joint damage. Tophi are chronic foreign body granuloma-like structures containing collections of MSU crystals encased by inflammatory cells and connective tissue, and are closely related to chronic inflammation and structural damage.
3. Biochemistry: Purine Metabolism and Uric Acid Production
Uric acid, a heterocyclic compound, is produced as a byproduct of purine metabolism and can be generated from endogenous as well as exogenous sources. The human body makes about 300–400 mg of uric acid per day, with most of it being produced in the liver. Purines degenerate into inosine and hypoxanthine; hypoxanthine is further metabolized into xanthine and uric acid in the presence of the enzyme xanthine oxidase.
In most mammals, uric acid is transformed to allantoin by the enzymatic activity of uricase. Allantoin, being a very soluble chemical, does not create any pathology. However, in humans, this enzyme is nonfunctional, so the end product of purine metabolism is uric acid, a weak acid that is relatively insoluble.
About two-thirds of uric acid is excreted through the kidney and one-third through the gastrointestinal tract. Urate excretion is believed to depend on a system that includes four components: glomerular filtration, proximal tubular reabsorption, secretion, and postsecretory reabsorption.
4. Inflammatory Mechanism
MSU crystals are recognized and phagocytosed by macrophages, which subsequently activates the NLRP3 inflammasome, produces interleukin-1β (IL-1β), and promotes the release of other pro-inflammatory factors and the aggregation of neutrophils, thereby triggering local or even systemic inflammatory responses.
The activated NLRP3 inflammasome complex cleaves pro-interleukin-1β into its active form, IL-1β, which is a key mediator of the inflammatory response in gout. IL-1β leads to the upregulation of cytokines and chemokines, resulting in the recruitment of neutrophils and other immune cells. Neutrophils recruited to the site of inflammation also play a role in resolving inflammation; aggregated neutrophil extracellular traps (NETs) trap and degrade cytokines and chemokines through NET-bound proteases, promoting the resolution of inflammation.
5. Body Systems Involved
5.1 Musculoskeletal System
The pathophysiology of gout involves complex and interacting processes, including chronic crystal–cell interactions that cause cartilage attrition, bone erosion, and tophi formation.
5.2 Renal System
High levels of uric acid in the urine and serum can lead to its deposition in joints and kidneys, leading to gout and nephrolithiasis. The presentation of nephrolithiasis includes renal colic or severe acute flank, abdominal, or back pain, often radiating to the groin; hematuria or brownish-colored urine; dysuria; nausea and vomiting. Urinary tract symptoms including fever, cloudy urine, and frequent urination may also be present.
5.3 Cardiovascular and Metabolic Systems
Gout and hyperuricemia are not merely causes of painful joint flares, but are systemic metabolic disorders linked to a broad spectrum of comorbidities such as cardiovascular diseases, chronic kidney disease, diabetes, insulin resistance, steatotic liver disease, osteoarthritis, and respiratory and eye diseases.
Hyperuricemia is a predictive factor for the development of hypertension, metabolic syndrome, type 2 diabetes, coronary artery disease, left ventricular hypertrophy, atrial fibrillation, myocardial infarction, stroke, heart failure, and chronic kidney disease.
Although gout's cardinal feature is inflammatory arthritis, it is closely associated with insulin resistance and considered a manifestation of the metabolic syndrome. Both gout and hyperuricemia are often associated with major cardiometabolic and renal comorbidities that drive persistently elevated premature mortality rates among gout patients.
Insulin resistance is a key feature of the metabolic syndrome, and because insulin resistance can reduce the renal excretion of urate, hyperuricemia and gout closely coexist with metabolic syndrome. In the US general population, the prevalence of metabolic syndrome has exceeded 71% among gout patients aged 40 years and older, compared with an overall prevalence of 22% among all US adults in the same time period.
6. Contributing and Associated Factors
6.1 Non-Modifiable Risk Factors
Risk factors for developing hyperuricemia and gout include non-modifiable risk factors such as sex, age, race, and genetics, and modifiable risk factors such as diet and lifestyle.
The pathogenesis of gout involves a complex interplay among genetic, metabolic, and environmental factors. Hyperuricemia is the main feature of gout and results from either overproduction or underexcretion of uric acid. Although hyperuricemia is a primary risk factor for gout, not all patients with elevated uric acid levels will develop gout, highlighting the condition's complexity.
In a meta-analysis of 6 cohort studies that included 16,760 patients, the variance in serum urate in the general population was better explained by genetic contributions compared to urate-modifying dietary factors, including beer, liquor, wine, soft drinks, skimmed milk, and meat. Each of these foods contributed approximately 1% of the variation in serum urate, while genetic polymorphisms were estimated to contribute 23.9% of the variation.
6.2 Purine-Rich Diet
Several risk factors identified in the literature include purine intake (especially from animal sources), fructose-sweetened beverages, alcohol consumption, high waist circumference, and elevated lipid levels, all of which contribute to recurrent gout flares and increased serum uric acid levels.
Purine-rich foods such as red meat contribute to increased uric acid production. A retrospective study from China reported that hyperuricemia increased by 2.40% with each 10 g intake of animal-derived food sources.
6.3 Fructose and Sugar-Sweetened Beverages
Fructose consumption is a potential risk factor for hyperuricemia because uric acid is a byproduct of fructose metabolism caused by the rapid consumption of adenosine triphosphate and accumulation of adenosine monophosphate and other purine nucleotides.
A meta-analysis including 22 studies and 235,790 participants found that sugar-sweetened beverage intake significantly increased the risk of hyperuricemia (OR = 1.33, 95% CI: 1.23–1.44) and gout (OR = 1.21; 95% CI: 1.11–1.32). Fructose consumption was strongly associated with increased gout risk (OR = 1.66, 95% CI: 1.27–2.18).
6.4 Alcohol
The ethanol in alcoholic beverages increases uric acid production and decreases the elimination of uric acid to urine by modulating kidney tubule function. Other ingredients in alcoholic beverages, such as purines, can also affect serum urate levels, so different beverages can affect serum urate levels differently. Consumption of alcohol, a high-fructose diet, and a high animal protein diet can increase the risk of gout and uric acid stones.
6.5 Obesity and Body Weight
Greater BMI is associated with increased risk of hyperuricemia and gout in a variety of studies. BMI has a small causal effect on serum urate, which may partially explain the increased prevalence of metabolic syndrome and cardiovascular disease among those with gout and hyperuricemia.
6.6 Medications and Other Conditions
Elevated uric acid can also be seen with accelerated purine degradation in high cell turnover states (e.g., hemolysis, rhabdomyolysis, tumor lysis) and decreased excretion (e.g., genetic disorders, renal insufficiency, metabolic syndrome).
7. Dietary Patterns Discussed in the Literature
7.1 Low-Purine Diet
Beyond medications, there is much interest in whether dietary approaches can be leveraged as an adjunct to optimize gout management and/or as an option for patients who do not yet meet indications for urate-lowering therapy. The degree to which diet impacts gout management remains controversial. Underexcretion of urate is a major contributor to hyperuricemia in gout, and the majority of urate production is related to the metabolism of endogenous purines rather than exogenous dietary sources.
7.2 DASH Diet
The DASH diet emphasizes whole grains, fruits, vegetables, and low-fat dairy products with low intake of red meats, sweets, and saturated fats, and thus encompasses many of the elements known to be inversely associated with hyperuricemia and gout, such as lower purine content.
A large prospective study provided the first evidence that the DASH diet is associated with a lower risk of incident gout, whereas the Western diet is associated with an increased risk of incident gout. The DASH diet may offer an attractive preventive dietary approach for gout risk.
Increasing evidence supports that consuming a DASH diet can continuously attenuate serum uric acid in hyperuricemia patients and reduce the incidence of gout.
7.3 Mediterranean Diet
Cohort studies have shown that a typical Western diet (based on high intake of red and processed meats, refined grains, and sugar-rich meals) is associated with a 42% higher risk of developing gout, whilst adherence to a Mediterranean-type diet is associated with a lower risk (RR 0.68, 95% CI 0.57 to 0.80).
Similar serum uric acid–lowering effects have been observed in research investigations of the Mediterranean diet.
7.4 Dairy Products
Dairy products, especially low-fat types, have been shown to lower serum uric acid levels and are associated with a lower risk of gout. Systematic review data also showed that dairy products and soy foods were negatively associated with gout.
7.5 Coffee
Coffee intake was negatively associated with gout; however, it was positively associated with hyperuricemia in women, but not in men in some studies, indicating mixed and sex-dependent associations.
7.6 Omega-3 Fatty Acids
A study examining dietary and supplemental omega-3 polyunsaturated fatty acids found that dietary n-3 PUFA-rich fish consumption, when adjusted for total purine intake, was associated with lower risk of recurrent gout flares, whereas n-3 PUFA supplementation alone, as taken in a self-directed manner, was not.
7.7 Weight Management and Physical Activity
The findings of a systematic review suggest that consuming polyunsaturated fatty acid-rich fish, regular physical activity, and increased vegetable intake may reduce gout flares, while high purine intake (especially from animal sources), excessive alcohol consumption, and obesity are risk factors for gout exacerbation.
8. Nutrients, Herbs, and Natural Ingredients
8.1 Vitamin C (Ascorbic Acid)
Traditional Use
Vitamin C is an essential water-soluble nutrient abundant in fruits and vegetables, used historically as part of dietary approaches to inflammatory conditions, though its specific use in traditional gout management predates modern clinical investigation.
Scientific Evidence
A randomized, controlled trial found that supplementation with 500 mg/day of vitamin C for 2 months reduces serum uric acid, suggesting that vitamin C might be beneficial in the prevention and management of gout and other urate-related diseases.
A large prospective study prospectively examined, over a 20-year period (1986–2006), the relation between vitamin C intake and the risk of incident gout in 46,994 male participants with no history of gout at baseline, using a supplementary questionnaire to ascertain the American College of Rheumatology criteria for gout. During the 20 years of follow-up, 1,317 confirmed incident cases of gout were documented. Compared with men with vitamin C intake less than 250 mg/d, the multivariate relative risk of gout was 0.83 (95% CI, 0.71–0.97) for total vitamin C intake of 500 to 999 mg/d, 0.66 (0.52–0.86) for 1000 to 1499 mg/d, and 0.55 (0.38–0.80) for 1500 mg/d or greater.
A subsequent meta-analysis of randomized controlled trials suggested that oral vitamin C supplementation results in modest serum uric acid reduction.
Proposed mechanisms include that vitamin C boosts renal plasma flow and glomerular filtration rate, inhibits urate-induced inflammation by acting as an antioxidant, and can inhibit the activity of the thioredoxin-interacting protein (TXNIP) in NF-κB signaling, which is involved in the activation of NLRP3 inflammasomes.
Evidence strength: Future trials are needed to determine whether vitamin C supplementation can reduce hyperuricemia or prevent incident and recurrent gout. The overall evidence is moderate: large prospective data are consistent, but available RCT data show a modest effect size and long-term gout-specific outcomes require further investigation.
8.2 Tart Cherry (Prunus cerasus)
Traditional Use
Tart cherry juice has been used for decades by some individuals for gout, based largely on anecdotal evidence of its efficacy and its antioxidant and anti-inflammatory properties.
Scientific Evidence
A systematic review searched PubMed, Embase, and the Cochrane Library. The six studies included reported decreases in the incidence and severity of gout following the ingestion of cherries. Gout patients regularly ingesting cherry extract or juice reported fewer gout flare-ups than those who did not supplement with cherry products.
Overall, a positive correlation was observed between tart cherry juice consumption and a decrease in serum uric acid concentration. Current evidence supports an association between cherry intake and a reduced risk of gout attacks. However, the authors were unable to conduct effective meta-analysis due to a lack of relevant studies and a high degree of variation in methodologies.
In one small RCT, 26 participants were randomly assigned to consume 240 mL/day of tart cherry juice or placebo for 4 weeks. The data suggested that 100% tart cherry juice reduces serum urate concentrations, mitigating hyperuricemia associated with gouty arthritis.
Several studies have reported that tart cherry juice or extract may reduce plasma urate and inflammatory biomarkers such as CRP, potentially via mechanisms involving xanthine oxidase inhibition and enhanced renal urate excretion.
In a more recent RCT, chronic supplementation with tart cherry extract led to a significant decrease in serum urate, with a mean reduction of 2.62 mg/dL, while the placebo group experienced a small but significant increase (+0.24 mg/dL).
Conflicting data: A 2026 randomized controlled crossover trial in 12 healthy adults found no statistically significant main effects of tart cherry juice on serum uric acid, vascular function, or C-reactive protein. Independent of drink type, serum uric acid and other markers changed with different temporal patterns throughout the day. The authors concluded that diurnal fluctuations may partly explain beneficial acute effects of cherry consumption reported in studies without a comparator.
Evidence strength: Preliminary to moderate. Evidence from systematic reviews is generally positive but is limited by small sample sizes, heterogeneous methodologies, and a lack of large, well-powered RCTs specifically in gout patients.
8.3 Quercetin
Traditional Use
Quercetin is a flavonoid polyphenol found abundantly in onions, apples, and tea. Its use as a general anti-inflammatory botanical compound has roots in various traditional herbal systems, though its specific use for gout is a modern nutritional application derived from its known biochemical properties.
Scientific Evidence
Elevated plasma uric acid concentration is a risk factor for gout, insulin resistance, and type 2 diabetes. Quercetin, a flavonoid found in high levels in onions, tea, and apples, inhibits xanthine oxidoreductase in vitro, the final step in intracellular uric acid production, indicating that quercetin might lower blood uric acid in humans.
A randomized, double-blinded, placebo-controlled, crossover trial determined the effects of 4 weeks of oral quercetin supplementation on plasma uric acid, blood pressure, and fasting glucose, recruiting 22 healthy males (aged 19–60 years) with baseline plasma uric acid concentrations in the higher healthy range. After quercetin treatment, plasma uric acid concentrations were significantly lowered by –26.5 µmol/L (95% CI: –76 to –45.5; P=0.008), without affecting fasting glucose, urinary excretion of uric acid, or blood pressure.
Evidence strength: Quercetin is biologically plausible but lacks the human trial data needed to recommend with confidence for gout management. The available RCT is small and conducted in pre-hyperuricemic men, not in established gout patients. Further large-scale trials are needed.
8.4 Curcumin (from Curcuma longa, Turmeric)
Traditional Use
Turmeric is the dried rhizome of Curcuma longa L., a member of the ginger family, recorded in the "Compendium of Materia Medica," and has traditional effects of promoting qi, breaking stasis, and unblocking meridians to relieve pain. It is also widely used as a food, with its powder used as a spice in curries, soups, and noodles.
Scientific Evidence
According to published studies, curcumin has shown xanthine oxidase and urate transporter-1 inhibitory properties, uric acid inhibitory characteristics, and antioxidant and anti-inflammatory effects. However, some studies have found no prominent reduction in uric acid levels.
A mouse model study found that curcumin treatment alleviates ankle joint swelling, reduces inflammatory cytokines IL-1β and TNF-α, and lowers serum uric acid concentrations. High-dose curcumin notably inhibited xanthine oxidase activity while enhancing renal expression of the urate transporter ABCG2, thereby promoting uric acid excretion. However, this evidence is preclinical only.
A randomized, placebo-controlled trial in 39 subjects with asymptomatic hyperuricemia found no difference in baseline serum urate between curcumin and placebo groups. After 8 weeks, serum urate decreased significantly in both groups (6.9% in the curcumin group; 5.0% in the placebo group), but there was no significant difference between the two groups in serum urate reduction.
Evidence strength: Despite the potency suggested in preclinical studies, an additional well-designed evaluation of curcumin is recommended before its therapeutic effectiveness is completely approved as an antigout agent. The single available human RCT showed no superiority over placebo for uric acid lowering. Human clinical evidence is currently insufficient.
8.5 Celery Seed (Apium graveolens)
Traditional Use
Celery seed has a long history of traditional use for gout and arthritis. In European and Western herbal traditions, the seeds of Apium graveolens were used as diuretic and anti-rheumatic preparations, typically as aqueous extracts or seed powders.
Scientific Evidence
Celery seed extract is a commonly promoted supplement with no RCT evidence for gout. Bromelain (pineapple enzyme) has general anti-inflammatory properties but has not been tested in gout-specific trials.
Celery seed contains compounds called phthalides and 3-n-butyl phthalide (3nB) that have been shown in animal studies and some human research to reduce uric acid production and increase its excretion. While the human clinical trial evidence is limited compared to cherry extract, the mechanism is considered plausible.
Evidence strength: Preliminary and insufficient. Evidence is based on preclinical and limited observational data. No rigorous human RCTs specific to gout have been published as of the current literature.
8.6 Bromelain (from Ananas comosus)
Traditional Use
Bromelain is a proteolytic enzyme complex derived from pineapple stem and fruit. It has been used in various traditional contexts as a digestive aid and was adopted in 20th-century naturopathic practice as a general anti-inflammatory agent.
Scientific Evidence
Bromelain, an enzyme found in pineapple, has general anti-inflammatory properties and is sometimes recommended for gout. The Arthritis Foundation acknowledges its immune-boosting and anti-inflammatory effects, but there is no specific clinical evidence showing it reduces gout flares or lowers uric acid.
Evidence strength: Insufficient for gout specifically. While the general anti-inflammatory properties of bromelain are recognized, no clinical trials examining its effect on serum urate or gout outcomes have been published.
8.7 Turmeric in Traditional Chinese Medicine (TCM) and Corn Silk
Traditional Use
Turmeric is recorded in the "Compendium of Materia Medica" and is used in Traditional Chinese Medicine with reported effects of promoting qi, breaking stasis, and unblocking meridians to relieve pain. In TCM practice, turmeric and corn silk (Zea mays stigma) have been used in combination formulas targeting conditions described as "damp-heat painful obstruction," which overlaps historically with the gout presentation.
Scientific Evidence
See section 8.4 above for the evidence on curcumin. Evidence for TCM combination formulas remains largely preclinical, and large-scale human trials have not been conducted for these traditional preparations in Western scientific literature.
9. Summary of Evidence Strength by Ingredient
- Vitamin C: Moderate evidence. Large prospective cohort data (46,994 men over 20 years) show a dose-dependent inverse association with gout risk. RCT data confirm modest serum urate reduction at 500 mg/day. Further long-term gout-specific RCTs needed.
- Tart Cherry (Prunus cerasus): Preliminary to moderate evidence. Systematic review of 6 studies shows association with reduced gout flares and lower serum urate. Some well-controlled trials show no acute effect. Evidence is promising but not definitive due to small sample sizes and methodological heterogeneity.
- Quercetin: Preliminary evidence. One small, well-designed RCT showed significant plasma uric acid reduction; mechanism (in vitro xanthine oxidase inhibition) is biologically plausible, but no large human trials have been conducted in gout patients.
- Curcumin/Turmeric: Insufficient evidence for uric acid lowering in humans. The single available RCT showed no superiority over placebo. Preclinical (animal) data are more encouraging. Human evidence for anti-inflammatory effects in gout specifically is also limited.
- Celery Seed: Very preliminary. Animal and limited mechanistic data only. No published RCTs for gout.
- Bromelain: Insufficient. No gout-specific clinical trials published. General anti-inflammatory properties acknowledged.
10. Lifestyle Factors
10.1 Physical Activity
The findings of a systematic review suggest that regular physical activity may reduce gout flares. Physical activity also supports weight management, which is independently associated with urate levels.
10.2 Hydration
Adequate fluid intake supports renal urate excretion. Urine alkalinization through diet has been studied in the context of uric acid nephrolithiasis: the therapeutic rationale for alkalinization of the urine pH to greater than 6.0 in patients forming uric acid stones relates to the differential solubility of monosodium urate versus non-ionized uric acid in aqueous solutions.
10.3 Weight Reduction
Lifestyle factors including increasing life span and wealth, excess nutritional status, and a growing prevalence of obesity in the population, as well as alcohol consumption, contribute to the rising incidence of hyperuricemia and gout. Caloric restriction and intentional weight loss are components of dietary intervention studies for gout management, which distinguished four groups of dietary interventions in hyperuricemia/gout research: calorie restriction and fasting, purine-low diets, Mediterranean-style diets, and supplements.
10.4 Alcohol Restriction
Among alcoholic beverages, beer has the highest impact on uric acid increases (it contains purines and inhibits excretion), spirits also raise uric acid, while wine carries lower risk than beer but still contributes if consumed frequently. Eating a low-purine diet and avoiding alcohol, particularly beer and spirits, sugar-sweetened beverages, heavy meals, and excessive intake of meat and seafood has been shown to reduce uric acid levels.
10.5 Overall Dietary Quality
A systematic review demonstrated that dietary and lifestyle factors have a remarkable impact on serum uric acid levels and the management of gout symptoms. Overall, the dietary factors appear to have a small effect on serum urate levels, and their impact on the long-term clinical course of gout is uncertain. This underscores the need to consider dietary modifications as complementary to, rather than replacements for, established clinical management approaches.
References
- Gout – StatPearls (NIH/NCBI Bookshelf)
- The pathogenesis of gout – PubMed (2025)
- Introduction: Management of Gout – NIH/NCBI Bookshelf
- Hyperuricosuria – StatPearls (NIH/NCBI Bookshelf)
- Hyperuricemia – StatPearls (NIH/NCBI Bookshelf)
- Editorial: Community series in advances in pathogenesis and therapies of gout, volume II – PMC
- Uric Acid – Clinical Methods (NIH/NCBI Bookshelf)
- Impact of lifestyle factors and dietary patterns on serum uric acid levels and disease activity in gout: a systematic review – PMC (2025)
- Role of diet in hyperuricemia and gout – ScienceDirect (2021)
- Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review – PMC
- Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review – MDPI Nutrients
- Effectiveness of Cherries in Reducing Uric Acid and Gout: A Systematic Review – PMC
- Consumption of 100% Tart Cherry Juice Reduces Serum Urate in Overweight and Obese Adults – PubMed
- Tart cherry juice has no acute effects on uric acid, vascular function and inflammation: A randomised crossover trial – PubMed (2026)
- Effects of Tart Cherry Extract Supplementation on Plasma Urate and CRP Levels: a Randomized Controlled Trial – Taylor & Francis
- Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial – PubMed
- The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial – PubMed
- Association between dietary vitamin C intake and gout among American adults – PMC
- Role of Vitamin C in Prophylaxis and Treatment of Gout—A Literature Review – PMC
- Vitamin C intake and the risk of gout in men: a prospective study – PubMed (Choi et al., 2009)
- Vitamin C Intake and the Risk of Gout in Men – A Prospective Study – PMC
- Effect of Oral Vitamin C Supplementation on Serum Uric Acid: A Meta-analysis of Randomized Controlled Trials – PMC
- Gout and Diet: A Comprehensive Review of Mechanisms and Management – PMC
- The DASH diet, Western diet, and risk of gout in men: prospective cohort study – PMC
- Effects of the DASH Diet and Sodium Intake on Serum Uric Acid – PMC
- Role of Diet in Hyperuricemia and Gout – PMC (NIH)
- The Role of Diet in Hyperuricemia and Gout – PMC (NIH)
- Treatment of Gout with TCM Using Turmeric and Corn Silk: A Concise Review and Pharmacology Network Analysis – PMC
- Curcumin/Turmeric: Their Effect on Serum Uric Acid Remains Unknown – PubMed
- Effect of Curcumin on Serum Urate in Asymptomatic Hyperuricemia: A Randomized Placebo-Controlled Trial – PubMed
- Curcumin ameliorates hyperuricemia and gout-induced damage via modulating the ROS-dependent NEK7-NLRP3 inflammasome activation – PubMed
- Anti-gout and Urate-lowering Potentials of Curcumin: A Review from Bench to Beside – PubMed
- Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications – PMC
- Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease – PubMed
- Comorbidities in gout and hyperuricemia: causality or epiphenomena? – PubMed
- Hyperuricemia, gout and the metabolic syndrome – PubMed
- Dietary intake of fructose increases purine de novo synthesis: A crucial mechanism for hyperuricemia – PMC
- Sugar-sweetened beverages and the risk of hyperuricemia and gout: a meta-analysis – PMC (2025)
- Effect of Dietary and Supplemental Omega-3 Polyunsaturated Fatty Acids on Risk of Recurrent Gout Flares – PubMed
- Evaluation of the Effects of a Supplement Composed by Quercetin, Rutin, Bromelain and L-Carnosine in Patients with Borderline Uricemia – Journal of Food and Nutrition Research
Go back